Stock Market Reviews

FLGT (Fulgent Genetics, Inc.) News

Get the latest news, insights, and market updates on FLGT (Fulgent Genetics, Inc.). Explore the news page 2 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• Fulgent Genetics Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags
  Fulgent Genetics ( NASDAQ:FLGT ) Second Quarter 2025 Results Key Financial Results Revenue: US$81.8m (up 15% from 2Q...
  Aug 3, 2025 - $FLGT
• Fulgent Genetics Inc (FLGT) Q2 2025 Earnings Call Highlights: Strong Core Revenue Growth Amid ...
  Fulgent Genetics Inc (FLGT) reports a 16% increase in core revenue and expands market reach, despite facing GAAP losses and increased operating expenses.
  Aug 2, 2025 - $FLGT
• Fulgent Genetics, Inc. (FLGT) Surpasses Q2 Earnings and Revenue Estimates
  Fulgent Genetics (FLGT) delivered earnings and revenue surprises of +130.43% and +7.80%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
  Aug 1, 2025 - $FLGT
• Fulgent Reports Second Quarter 2025 Financial Results
  EL MONTE, Calif., August 01, 2025--Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent," or the "Company"), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced financial results for its second quarter ended June 30, 2025.
  Aug 1, 2025 - $FLGT
• Why Fulgent Genetics Stock Was Crushing It on Friday
  The next-generation diagnostics specialist had a beat-and-raise second quarter.
  Aug 1, 2025 - $FLGT
• Fulgent Genetics Receives EU CE Mark for FulgentExome & FulgentPLM
  EL MONTE, Calif., July 17, 2025--Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent," or the "Company"), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced it has received CE certification under the European Union (EU)’s In Vitro Diagnostic Regulation (EU) 2017/746 (IVDR) for its germline next-generation sequencing (NGS) system, which includes FulgentExome and Fulgent Pipeline Manager (PLM). Based on available info
  Jul 17, 2025 - $FLGT
• Fulgent to Announce Second Quarter 2025 Financial Results on Friday, August 1, 2025
  EL MONTE, Calif., July 10, 2025--Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent" or the "Company"), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced that it will release its second quarter 2025 financial results before the market opens on Friday, August 1, 2025. Management will host a conference call for the investment community the same day at 8:30 AM ET (5:30 AM PT) to discuss the results and answer questio
  Jul 10, 2025 - $FLGT
• Fulgent Genetics, Inc. (NASDAQ:FLGT) is definitely on the radar of institutional investors who own 48% of the company
  Key Insights Institutions' substantial holdings in Fulgent Genetics implies that they have significant influence over...
  Jun 2, 2025 - $FLGT
• Fulgent Genetics Inc (FLGT) Q1 2025 Earnings Call Highlights: Navigating Growth and Challenges
  Fulgent Genetics Inc (FLGT) reports strong momentum in key sectors despite facing revenue and margin pressures.
  May 3, 2025 - $FLGT
• Fulgent Genetics, Inc. (FLGT) Q1 Earnings and Revenues Beat Estimates
  Fulgent Genetics (FLGT) delivered earnings and revenue surprises of 121.05% and 2.76%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
  May 2, 2025 - $FLGT